Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-20
DOI
10.3389/fimmu.2017.01589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
- (2017) Iebe Rossey et al. Nature Communications
- Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence
- (2017) Yariv Mazor et al. Scientific Reports
- Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein–Protein Interaction Analysis, and Protein Function Exploration
- (2017) Els Beghein et al. Frontiers in Immunology
- Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases
- (2017) Carla F. C. Fernandes et al. Frontiers in Immunology
- Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging
- (2017) Tamarand Lee Darling et al. Frontiers in Immunology
- VHH antibodies: emerging reagents for the analysis of environmental chemicals
- (2016) Candace S. Bever et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Nanobodies as therapeutics: big opportunities for small antibodies
- (2016) Sophie Steeland et al. DRUG DISCOVERY TODAY
- Brain penetration, target engagement, and disposition of the blood–brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1
- (2016) Carl I. Webster et al. FASEB JOURNAL
- Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications
- (2016) Yongzhong Wang et al. International Journal of Nanomedicine
- Development by Genetic Immunization of Monovalent Antibodies (Nanobodies) Behaving as Antagonists of the Human ChemR23 Receptor
- (2016) Xavier Peyrassol et al. JOURNAL OF IMMUNOLOGY
- NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
- (2016) Sandrine Moutel et al. eLife
- DNA immunization as a technology platform for monoclonal antibody induction
- (2016) Shuying Liu et al. Emerging Microbes & Infections
- Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor
- (2015) Kyriakos P. Papadopoulos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nanobodies and recombinant binders in cell biology
- (2015) Jonas Helma et al. JOURNAL OF CELL BIOLOGY
- Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform
- (2015) Alex Klarenbeek et al. mAbs
- Monitoring Interactions and Dynamics of Endogenous Beta-catenin With Intracellular Nanobodies in Living Cells
- (2015) Bjoern Traenkle et al. MOLECULAR & CELLULAR PROTEOMICS
- Tetrameric and Homodimeric Camelid IgGs Originate from the Same IgH Locus
- (2014) I. Achour et al. JOURNAL OF IMMUNOLOGY
- Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications
- (2014) Junrong Yan et al. Journal of Translational Medicine
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Nanobody-based products as research and diagnostic tools
- (2014) Thomas De Meyer et al. TRENDS IN BIOTECHNOLOGY
- Nanobody: The “Magic Bullet” for Molecular Imaging?
- (2014) Rubel Chakravarty et al. Theranostics
- Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
- (2014) Laura E. McCoy et al. PLoS Pathogens
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growthin Vivo
- (2013) David Maussang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-Domain Antibody-Based and Linker-Free Bispecific Antibodies Targeting Fc RIII Induce Potent Antitumor Activity without Recruiting Regulatory T Cells
- (2013) C. Rozan et al. MOLECULAR CANCER THERAPEUTICS
- Nanobodies and their potential applications
- (2013) Gholamreza Hassanzadeh-Ghassabeh et al. Nanomedicine
- Development of177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators
- (2012) Matthias D'Huyvetter et al. Contrast Media & Molecular Imaging
- Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging
- (2012) Tengfei Li et al. FASEB JOURNAL
- Nanobodies®: New ammunition to battle viruses
- (2011) Peter Vanlandschoot et al. ANTIVIRAL RESEARCH
- Immuno-imaging using nanobodies
- (2011) Ilse Vaneycken et al. CURRENT OPINION IN BIOTECHNOLOGY
- A Case Of Convergence: Why Did a Simple Alternative to Canonical Antibodies Arise in Sharks and Camels?
- (2011) Martin F. Flajnik et al. PLOS BIOLOGY
- Research and development of next generation of antibody-based therapeutics
- (2010) Jing Li et al. ACTA PHARMACOLOGICA SINICA
- A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines
- (2010) Dorota Smolarek et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Novel Promiscuous Class of Camelid Single-Domain Antibody Contributes to the Antigen-Binding Repertoire
- (2010) N. Deschacht et al. JOURNAL OF IMMUNOLOGY
- A one-step exclusion-binding procedure for the purification of functional heavy-chain and mammalian-type γ-globulins from camelid sera
- (2009) Michel R. Blanc et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
- (2009) Janusz Wesolowski et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Development trends for therapeutic antibody fragments
- (2009) Aaron L Nelson et al. NATURE BIOTECHNOLOGY
- Immunological applications of single-domain llama recombinant antibodies isolated from a naïve library
- (2009) Ana Monegal et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Isolation and Functional Characterization of Single Domain Antibody Modulators of Caspase-3 and Apoptosis
- (2008) Katrina McGonigal et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Single-domain antibodies as building blocks for novel therapeutics
- (2008) D SAERENS et al. CURRENT OPINION IN PHARMACOLOGY
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol
- (2008) Patrick J. Doyle et al. MOLECULAR IMMUNOLOGY
- Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens
- (2008) Emilio A. De Simone et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Single-domain antibody fragments with high conformational stability
- (2002) Mireille Dumoulin et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More